|
|
Gene Symbol |
IL23A |
|
Aliases |
IL-23, IL-23A, IL23P19, P19, SGRF |
|
Entrez Gene ID |
|
|
Gene Name |
Interleukin 23 subunit alpha |
|
Chromosomal Location |
12q13.3 |
|
HGNC ID |
|
|
Summary |
This gene encodes a subunit of the heterodimeric cytokine interleukin 23 (IL23). IL23 is composed of this protein and the p40 subunit of interleukin 12 (IL12B). The receptor of IL23 is formed by the beta 1 subunit of IL12 (IL12RB1) and an IL23 specific subunit, IL23R. Both IL23 and IL12 can activate the transcription activator STAT4, and stimulate the production of interferon-gamma (IFNG). In contrast to IL12, which acts mainly on naive CD4(+) T cells, IL23 preferentially acts on memory CD4(+) T cells. [provided by RefSeq, Jul 2008]
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0002230 |
Biological process |
Positive regulation of defense response to virus by host |
IDA |
12421946 |
GO:0002827 |
Biological process |
Positive regulation of T-helper 1 type immune response |
IDA |
15114670 |
GO:0002827 |
Biological process |
Positive regulation of T-helper 1 type immune response |
NAS |
20027291 |
GO:0002827 |
Biological process |
Positive regulation of T-helper 1 type immune response |
TAS |
16751425 |
GO:0010536 |
Biological process |
Positive regulation of activation of Janus kinase activity |
IBA |
21873635 |
GO:0010536 |
Biological process |
Positive regulation of activation of Janus kinase activity |
IDA |
12023369 |
GO:0032693 |
Biological process |
Negative regulation of interleukin-10 production |
IMP |
16751425 |
GO:0032725 |
Biological process |
Positive regulation of granulocyte macrophage colony-stimulating factor production |
IDA |
20027291 |
GO:0032729 |
Biological process |
Positive regulation of interferon-gamma production |
IDA |
11114383, 17888176, 20027291 |
GO:0032729 |
Biological process |
Positive regulation of interferon-gamma production |
TAS |
19088061 |
GO:0032733 |
Biological process |
Positive regulation of interleukin-10 production |
IDA |
15265908 |
GO:0032733 |
Biological process |
Positive regulation of interleukin-10 production |
TAS |
18675459 |
GO:0032735 |
Biological process |
Positive regulation of interleukin-12 production |
IDA |
20027291 |
GO:0032740 |
Biological process |
Positive regulation of interleukin-17 production |
IDA |
16482511, 16751425, 17888176 |
GO:0032760 |
Biological process |
Positive regulation of tumor necrosis factor production |
IMP |
16751425 |
GO:0032816 |
Biological process |
Positive regulation of natural killer cell activation |
IC |
20027291 |
GO:0032819 |
Biological process |
Positive regulation of natural killer cell proliferation |
IDA |
19088061 |
GO:0034105 |
Biological process |
Positive regulation of tissue remodeling |
IC |
16482511 |
GO:0042102 |
Biological process |
Positive regulation of T cell proliferation |
IBA |
21873635 |
GO:0042102 |
Biological process |
Positive regulation of T cell proliferation |
IDA |
12023369 |
GO:0042104 |
Biological process |
Positive regulation of activated T cell proliferation |
IDA |
11114383 |
GO:0042509 |
Biological process |
Regulation of tyrosine phosphorylation of STAT protein |
IDA |
12023369 |
GO:0042531 |
Biological process |
Positive regulation of tyrosine phosphorylation of STAT protein |
IDA |
12023369, 19088061 |
GO:0045672 |
Biological process |
Positive regulation of osteoclast differentiation |
IDA |
17888176 |
GO:0050729 |
Biological process |
Positive regulation of inflammatory response |
IC |
16482511 |
GO:0050829 |
Biological process |
Defense response to Gram-negative bacterium |
IDA |
15114670, 20027291 |
GO:0051135 |
Biological process |
Positive regulation of NK T cell activation |
IC |
20027291 |
GO:0051135 |
Biological process |
Positive regulation of NK T cell activation |
IDA |
19088061 |
GO:0051142 |
Biological process |
Positive regulation of NK T cell proliferation |
IDA |
19088061 |
GO:1901224 |
Biological process |
Positive regulation of NIK/NF-kappaB signaling |
TAS |
20428758 |
GO:2000330 |
Biological process |
Positive regulation of T-helper 17 cell lineage commitment |
IBA |
21873635 |
GO:0070743 |
Cellular component |
Interleukin-23 complex |
IBA |
21873635 |
GO:0070743 |
Cellular component |
Interleukin-23 complex |
IDA |
11114383 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
11114383, 12023369, 18680750, 25416956, 29997244 |
GO:0045519 |
Molecular function |
Interleukin-23 receptor binding |
IBA |
21873635 |
GO:0045519 |
Molecular function |
Interleukin-23 receptor binding |
IDA |
11114383 |
|
Protein Information |
|
Protein Name |
Interleukin-23 subunit alpha, IL-23 subunit alpha, IL-23-A, IL-23p19, JKA3 induced upon T-cell activation, interleukin 23 p19 subunit, interleukin 23, alpha subunit p19, interleukin-23 subunit p19, interleukin-six, G-CSF related factor |
|
Function |
Associates with IL12B to form the IL-23 interleukin, a heterodimeric cytokine which functions in innate and adaptive immunity. IL-23 may constitute with IL-17 an acute response to infection in peripheral tissues. IL-23 binds to a heterodimeric receptor complex composed of IL12RB1 and IL23R, activates the Jak-Stat signaling cascade, stimulates memory rather than naive T-cells and promotes production of proinflammatory cytokines. IL-23 induces autoimmune inflammation and thus may be responsible for autoimmune inflammatory diseases and may be important for tumorigenesis. |
|
|
UniProt |
|
|
PDB |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF16649 |
IL23 |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000217407 |
|
P18428 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Endocrine System Diseases |
PCOS |
|
Immune System Diseases |
Rheumatoid Arthritis |
|
Skin and Connective Tissue Diseases |
Pustulosis |
|
Psoriasis |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
ADAMTS1, ADAMTS5, ADAMTS9, IL?17A, IL?33,CRP, TNF-?, IL-1, IL-6, IL-18, ADAMTS16, IL-6 |
Insulin resistance, impaired glucose tolerance (IGT), type 2 diabetes mellitus (DM type 2) , metabolic syndrome, malignancy and cardiovascular diseases. |
|
Rotterdam criteria |
Direct
|
43 patients undergoing IVF treatment—21 diagnosed as PCOS and 22 diagnosed as normal ovulatory women (the control group) |
ADAMTS and IL molecules have a role in the pathogenesis of the PCOS. |
|
|
|
|